Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Borman

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
The Journal of Antimicrobial Chemotherapy|September 21, 2019
In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiaeZoltán Tóth, Lajos Forgács, Jeffrey B Locke, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United KingdomAndrew M Borman, Julian Muller, Jo Walsh-Quantick, et al.
The Journal of Infection|September 27, 2019
Candida auris outbreak: Mortality, interventions and cost of sustaining controlSurabhi K Taori, Kirstin Khonyongwa, Iain Hayden, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2020
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution methodAndrew M Borman, Julian Muller, Jo Walsh-Quantick, et al.
Microbiology Spectrum|March 5, 2024
Comparative transcriptional analysis of <i>Candida auris</i> biofilms following farnesol and tyrosol treatmentÁgnes Jakab, Fruzsina Kovács, Noémi Balla, et al.
Pharmaceutics|May 27, 2023
In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four <i>Candida auris</i> CladesAwid Adnan, Andrew M Borman, Zoltán Tóth, et al.
Antibiotics (Basel, Switzerland)|November 24, 2022
Synergistic Interaction of Caspofungin Combined with Posaconazole against <i>FKS</i> Wild-Type and Mutant <i>Candida auris</i> Planktonic Cells and BiofilmsNoémi Balla, Fruzsina Kovács, Bence Balázs, et al.
Emerging Microbes & Infections|June 4, 2020
Comparison of <i>in vivo</i> pathogenicity of four <i>Candida auris</i> clades in a neutropenic bloodstream infection murine modelLajos Forgács, Andrew M Borman, Eszter Prépost, et al.
FEMS Microbiology Letters|June 3, 2011
Purpureocillium, a new genus for the medically important Paecilomyces lilacinusJennifer Luangsa-Ard, Jos Houbraken, Tineke van Doorn, et al.
Medical Mycology|November 12, 2010
Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungiAndrew M Borman, Michael D Palmer, Laurence Delhaes, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
The Journal of Antimicrobial Chemotherapy|September 21, 2019
In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiaeZoltán Tóth, Lajos Forgács, Jeffrey B Locke, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United KingdomAndrew M Borman, Julian Muller, Jo Walsh-Quantick, et al.
The Journal of Infection|September 27, 2019
Candida auris outbreak: Mortality, interventions and cost of sustaining controlSurabhi K Taori, Kirstin Khonyongwa, Iain Hayden, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2020
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution methodAndrew M Borman, Julian Muller, Jo Walsh-Quantick, et al.
Microbiology Spectrum|March 5, 2024
Comparative transcriptional analysis of <i>Candida auris</i> biofilms following farnesol and tyrosol treatmentÁgnes Jakab, Fruzsina Kovács, Noémi Balla, et al.
Pharmaceutics|May 27, 2023
In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four <i>Candida auris</i> CladesAwid Adnan, Andrew M Borman, Zoltán Tóth, et al.
Antibiotics (Basel, Switzerland)|November 24, 2022
Synergistic Interaction of Caspofungin Combined with Posaconazole against <i>FKS</i> Wild-Type and Mutant <i>Candida auris</i> Planktonic Cells and BiofilmsNoémi Balla, Fruzsina Kovács, Bence Balázs, et al.
Emerging Microbes & Infections|June 4, 2020
Comparison of <i>in vivo</i> pathogenicity of four <i>Candida auris</i> clades in a neutropenic bloodstream infection murine modelLajos Forgács, Andrew M Borman, Eszter Prépost, et al.
FEMS Microbiology Letters|June 3, 2011
Purpureocillium, a new genus for the medically important Paecilomyces lilacinusJennifer Luangsa-Ard, Jos Houbraken, Tineke van Doorn, et al.
Medical Mycology|November 12, 2010
Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungiAndrew M Borman, Michael D Palmer, Laurence Delhaes, et al.
Pageof 12